Disruption of the Lecithin:Retinol Acyltransferase Gene Makes Mice More Susceptible to Vitamin A Deficiency*

  1. Limin Liu1 and
  2. Lorraine J. Gudas, Supported by National Institutes of Health Grants 5R01DE10389 and National Institutes of Health 5R01CA0975432
  1. Department of Pharmacology, Weill Medical College of Cornell University, New York, New York 10021
  1. 2 To whom correspondence should be addressed: Dept. of Pharmacology, Weill Medical College of Cornell University, 1300 York Ave., New York, NY 10021. Tel.: 212-746-6250; Fax: 212-746-8858; E-mail: ljgudas{at}med.cornell.edu.

Abstract

Lecithin:retinol acyltransferase (LRAT) catalyzes the esterification of retinol (vitamin A) in the liver and in some extrahepatic tissues, including the lung. We produced an LRAT gene knock-out mouse strain and assessed whether LRAT-/- mice were more susceptible to vitamin A deficiency than wild type (WT) mice. After maintenance on a vitamin A-deficient diet for 6 weeks, the serum retinol level was 1.34 ± 0.32 μm in WT mice versus 0.13 ± 0.06 μm in LRAT-/- mice (p < 0.05). In liver, lung, eye, kidney, brain, tongue, adipose tissue, skeletal muscle, and pancreas, the retinol levels ranged from 0.05 pmol/mg (muscle and tongue) to 17.35 ± 2.66 pmol/mg (liver) in WT mice. In contrast, retinol was not detectable (<0.007 pmol/mg) in most tissues from LRAT-/- mice after maintenance on a vitamin A-deficient diet for 6 weeks. Cyp26A1 mRNA was not detected in hepatic tissue samples from LRAT-/- mice but was detected in WT mice fed the vitamin A-deficient diet. These data indicate that LRAT-/- mice are much more susceptible to vitamin A deficiency and should be an excellent animal model of vitamin A deficiency. In addition, the retinol levels in serum rapidly increased in the LRAT-/- mice upon re-addition of vitamin A to the diet, indicating that serum retinol levels in LRAT-/- mice can be conveniently modulated by the quantitative manipulation of dietary retinol.

Footnotes

  • 3 The abbreviations used are: RA, all-trans-retinoic acid; CRBP, cellular retinol-binding protein; CYP26, cytochrome P450 retinoic acid hydroxylase; Dhrs1, short-chain dehydrogenase/reductase member 1; ES, embryonic stem; HPLC, high performance liquid chromatography; LRAT, lecithin:retinol acyltransferase; PBS, phosphate-buffered saline; RT, reverse transcription; WT, wild type; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.

  • * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 Supported by National Institutes of Health Cancer Pharmacology Training Grant 5T32CA62948.

    • Received September 1, 2005.
    • Revision received September 15, 2005.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement